Retirement Planning Co of New England Inc. Has $1.70 Million Stake in Aflac Incorporated (NYSE:AFL)

Retirement Planning Co of New England Inc. boosted its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 99.1% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,241 shares of the financial services provider's stock after buying an additional 7,585 shares during the quarter. Retirement Planning Co of New England Inc.'s holdings in Aflac were worth $1,695,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of AFL. Valued Wealth Advisors LLC increased its holdings in shares of Aflac by 24.4% during the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider's stock worth $55,000 after purchasing an additional 97 shares during the period. Phillips Wealth Planners LLC increased its holdings in shares of Aflac by 1.5% during the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider's stock worth $711,000 after purchasing an additional 100 shares during the period. Optas LLC increased its holdings in shares of Aflac by 3.5% during the first quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock worth $328,000 after purchasing an additional 101 shares during the period. Family Legacy Inc. increased its holdings in shares of Aflac by 4.3% during the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock worth $270,000 after purchasing an additional 107 shares during the period. Finally, Titleist Asset Management LLC increased its holdings in shares of Aflac by 3.4% during the fourth quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider's stock worth $344,000 after purchasing an additional 110 shares during the period. Institutional investors and hedge funds own 67.44% of the company's stock.

Wall Street Analyst Weigh In

AFL has been the topic of several recent research reports. Piper Sandler raised their target price on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. UBS Group raised their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Morgan Stanley raised their target price on shares of Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Finally, Raymond James Financial decreased their price objective on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research note on Thursday, May 29th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Aflac has a consensus rating of "Hold" and a consensus price target of $107.07.

Aflac Price Performance

NYSE:AFL traded up $0.36 during mid-day trading on Friday, reaching $101.78. The stock had a trading volume of 4,577,769 shares, compared to its average volume of 2,163,187. The stock has a 50-day simple moving average of $103.41 and a two-hundred day simple moving average of $105.18. The stock has a market capitalization of $55.03 billion, a PE ratio of 15.90, a P/E/G ratio of 3.14 and a beta of 0.81. Aflac Incorporated has a 12 month low of $92.44 and a 12 month high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business's quarterly revenue was down 37.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.66 EPS. On average, equities analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were issued a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.28%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Insider Transactions at Aflac

In related news, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the transaction, the director owned 6,728 shares in the company, valued at $711,149.60. The trade was a 29.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director owned 26,096 shares in the company, valued at approximately $2,786,791.84. The trade was a 3.69% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 40,750 shares of company stock worth $4,304,295. Company insiders own 0.90% of the company's stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.